Paper33892007
Impact of alcohol on the progression of HCV-related liver disease: A systematic review and meta-analysis.
Llamosas-Falcón L and 7 others. J Hepatol, 2021. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Impact of alcohol on the progression of HCV-related liver disease: A systematic review and meta-analysis. Papers, record 33892007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33892007
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alcohol Drinking | Major topic |
| Hepatitis C | Major topic |
| Humans | |
| Liver Diseases | |
| Risk Factors |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 001 | World Health Organization | International | PubMed | PubMed | |
| SMN-13950 | CIHR | Canada | PubMed | PubMed | |
| R01 AA024443 | NIAAA NIH HHS | United States | R01AA024443 | PubMed and NIH | NIH RePORTER |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42503018 | Alcohol Use and Attributable Burden of Disease in the World Health Organization Western Pacific Region. | Drug Alcohol Rev | 2026 | https://conductscience.org/library/papers/42503018 | PubMed |
| 42449623 | Risk of Liver and Non-Liver Malignancy in HCV-Infected Patients with Cirrhosis After Direct-Acting Antiviral Treatment. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449623 | PubMed |
| 42343625 | Chronic viral hepatitis with concurrent metabolic dysfunction-associated steatotic liver disease: dual etiology challenges. | Clin Mol Hepatol | 2026 | https://conductscience.org/library/papers/42343625 | PubMed |
| 42022366 | Steatotic liver disease and chronic viral hepatitis. | Clin Exp Hepatol | 2025 | https://conductscience.org/library/papers/42022366 | PubMed |
| 41874025 | Prevalence of Viral Hepatitis Antibodies Among Alcoholics in Croatia: A Single Center's Results. | Antibodies (Basel) | 2026 | https://conductscience.org/library/papers/41874025 | PubMed |
| 41804499 | A Systematic Review and Narrative Synthesis of Factors Impacting Late Diagnosis of Chronic Hepatitis B and C. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/41804499 | PubMed |
| 41510522 | A Practical Guide to Conducting Dose-Response Meta-Analyses in Epidemiology. | Methodology (Gott) | 2025 | https://conductscience.org/library/papers/41510522 | PubMed |
| 40078198 | Dose-dependent Relationship between Alcohol Consumption and the Risks of Hepatitis B Virus-associated Cirrhosis and Hepatocellular Carcinoma: A Meta-analysis and Systematic Review. | J Clin Transl Hepatol | 2025 | https://conductscience.org/library/papers/40078198 | PubMed |
| 39337105 | Trends in Hospitalizations of Patients with Hepatitis C Virus in Poland between 2012 and 2022. | J Clin Med | 2024 | https://conductscience.org/library/papers/39337105 | PubMed |
| 37751206 | Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37751206 | PubMed |
| 37684424 | How does alcohol use impact morbidity and mortality of liver cirrhosis? A systematic review and dose-response meta-analysis. | Hepatol Int | 2024 | https://conductscience.org/library/papers/37684424 | PubMed |
| 37587323 | Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort). | Qual Life Res | 2023 | https://conductscience.org/library/papers/37587323 | PubMed |
| 37375444 | Looking at the Molecular Target of NS5A Inhibitors throughout a Population Highly Affected with Hepatitis C Virus. | Pathogens | 2023 | https://conductscience.org/library/papers/37375444 | PubMed |
| 37109461 | Predictors of Significant Liver Fibrosis in People with Chronic Hepatitis C Who Inject Drugs in the Czech Republic. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37109461 | PubMed |
| 36926309 | Sex-specific association between alcohol consumption and liver cirrhosis: An updated systematic review and meta-analysis. | Front Gastroenterol (Lausanne) | 2022 | https://conductscience.org/library/papers/36926309 | PubMed |
| 36515952 | Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment. | JAMA Netw Open | 2022 | https://conductscience.org/library/papers/36515952 | PubMed |
| 34579021 | The Global Impact of Alcohol Consumption on Premature Mortality and Health in 2016. | Nutrients | 2021 | https://conductscience.org/library/papers/34579021 | PubMed |
| 34444809 | Dose-Response Relationships between Levels of Alcohol Use and Risks of Mortality or Disease, for All People, by Age, Sex, and Specific Risk Factors. | Nutrients | 2021 | https://conductscience.org/library/papers/34444809 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33892007
GET https://conductscience.org/api/papers/v1/33892007/authors